Profile data is unavailable for this security.
About the company
PT Merck Tbk is an Indonesia-based company. The Company engages in the pharmaceutical industry, trading, leasing, and property management service. The Company operates through two segments, namely Biopharma and Consumer Health. The Biopharma segment focuses on ethical products, while the Consumer Health segment offers over-the-counter products. It manufactures and sells various pharmaceutical products, including finished products, bulk products, active ingredients, and other materials. The Company serves customers in Indonesia and offshore countries.
- Revenue in IDR (TTM)1.10tn
- Net income in IDR178.51bn
- Incorporated1970
- Employees369.00
- LocationMerck Tbk PTJl. TB. Simatupang No. 8, Pasar ReboJAKARTA TIMUR 13760IndonesiaIDN
- Phone+62 28565600
- Fax+62 28565601
- Websitehttps://www.merckgroup.com/id-id
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infant Bacterial Therapeutics AB | 0.00 | -150.38bn | 1.38tn | 10.00 | -- | 6.11 | -- | -- | -5.92 | -5.92 | 0.00 | 9.23 | 0.00 | -- | -- | 0.00 | -38.19 | -22.82 | -48.56 | -24.41 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -11.24 | -- | -- | -- |
| Vetnostrum Animal Health Co Ltd | 733.14bn | 64.03bn | 1.41tn | 185.00 | 20.75 | 2.01 | 13.56 | 1.92 | 1.74 | 1.74 | 19.77 | 17.95 | 0.9165 | 2.78 | 6.48 | 7,399,816.00 | 8.00 | 7.64 | 9.81 | 10.10 | 31.85 | 31.00 | 8.73 | 9.19 | 2.18 | 73.65 | 0.0174 | 49.57 | 7.17 | 3.68 | 49.15 | 3.98 | -30.60 | -- |
| Merck Tbk PT | 1.10tn | 178.51bn | 1.43tn | 369.00 | 8.03 | 1.72 | 6.46 | 1.31 | 398.45 | 398.45 | 2,448.93 | 1,859.85 | 1.15 | 1.74 | 6.55 | 2,917,872,000.00 | 18.74 | 14.65 | 21.71 | 18.93 | 40.15 | 39.72 | 16.27 | 14.77 | 3.79 | -- | 0.0179 | 73.42 | 7.83 | 6.84 | -13.90 | 14.42 | -10.51 | 5.51 |
| Accent Microcell Ltd | 516.50bn | 64.42bn | 1.43tn | 192.00 | 21.12 | 3.09 | 19.84 | 2.78 | 15.24 | 15.24 | 122.20 | 104.07 | 1.12 | 4.14 | 5.32 | 14,474,330.00 | 13.99 | -- | 15.95 | -- | 39.96 | -- | 12.47 | -- | 3.01 | 76.48 | 0.0046 | -- | 7.77 | -- | 9.60 | -- | -- | -- |
| Inter Pharma PCL | 1.17tn | 60.70bn | 1.44tn | 162.00 | 23.78 | 1.31 | 11.10 | 1.24 | 0.185 | 0.185 | 3.56 | 3.36 | 0.6962 | 3.64 | 6.89 | 13,293,500.00 | 4.00 | 3.98 | 5.34 | 5.19 | 40.52 | 40.40 | 5.75 | 6.01 | 1.23 | 7.92 | 0.1549 | 23.26 | 6.52 | 38.23 | -26.60 | -3.03 | 160.41 | -- |
| Uni-Bio Science Group Ltd | 1.27tn | 196.70bn | 1.48tn | 504.00 | 7.55 | 1.79 | 6.00 | 1.16 | 0.0152 | 0.0152 | 0.0976 | 0.0641 | 1.13 | 3.62 | 9.18 | 1,210,657.00 | 17.51 | 6.21 | 22.17 | 8.56 | 82.19 | 80.72 | 15.49 | 4.96 | 3.22 | 59.39 | 0.22 | 1,633.58 | 14.08 | 21.43 | 16.79 | 102.04 | 32.65 | -- |
| Fusen Pharmaceutical Co Ltd | 587.73bn | -426.73bn | 1.48tn | 1.05k | -- | 1.75 | -- | 2.52 | -0.2681 | -0.2681 | 0.3692 | 0.5309 | 0.1875 | 1.11 | 4.05 | 241,331.70 | -13.62 | -2.83 | -32.04 | -5.40 | 41.39 | 51.61 | -72.61 | -8.00 | 0.4241 | -0.4344 | 0.5137 | -- | -42.36 | -4.36 | -420.39 | -- | -17.55 | -- |
| Remus Pharmaceuticals Ltd | 1.39tn | 60.51bn | 1.48tn | 68.00 | 21.78 | 2.60 | 18.15 | 1.07 | 31.11 | 31.11 | 701.20 | 260.51 | 1.89 | 9.07 | 7.21 | 109,981,700.00 | 10.44 | 14.37 | 18.44 | 28.60 | 13.01 | 19.39 | 5.51 | 8.39 | 1.07 | 35.59 | 0.0452 | 3.59 | 191.93 | 120.44 | 34.98 | 104.56 | 48.07 | -- |
Data as of Feb 13 2026. Currency figures normalised to Merck Tbk PT's reporting currency: Indonesian Rupiah IDR
